Myocardial Infarction in Patients with and without COVID-19: Comparisons of Characteristics, Clinical Courses, and

Hossein Sheibani1, Mehran Gheshlaghi2, Somayeh Shah Hosseini3

  • 1Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.

Insights

COVID-19 significantly impacts patients with acute myocardial infarction (MI), leading to more frequent non-ST-elevation MI, lower ejection fractions, and arrhythmias. These findings highlight the need for specialized care for COVID-19 patients experiencing acute coronary syndrome.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 is a global health emergency impacting multiple organs, including myocardial cells.
  • Acute coronary syndrome (ACS) outcomes are influenced by comorbidities, with COVID-19 being a significant factor.
  • COVID-19 can alter the clinical course and prognosis of acute myocardial infarction (MI).

Purpose of the Study:

  • To compare the clinical course and outcomes of myocardial infarction (MI) in patients with and without concurrent COVID-19 infection.
  • To identify practical factors influencing MI outcomes in the presence of COVID-19.

Main Methods:

  • A cross-sectional study involving 180 patients diagnosed with acute MI.
  • Comparison of clinical and angiographic data between 80 patients with COVID-19 and 100 patients without COVID-19.
  • Analysis of factors such as MI type, ejection fraction, arrhythmias, and coronary artery disease extent.

Main Results:

  • Patients with COVID-19 had a higher frequency of non-ST-elevation MI (NSTEMI), lower ejection fractions (<30%), and more arrhythmias compared to non-COVID-19 patients.
  • Single-vessel disease was more common in the COVID-19 group, whereas double-vessel disease predominated in the non-COVID-19 group.
  • Significant differences were observed in MI type, ejection fraction, and arrhythmias between the groups (P=0.006, 0.003, P<0.001, respectively).

Conclusions:

  • COVID-19 infection is associated with a more severe presentation of acute myocardial infarction.
  • Patients with acute coronary syndrome (ACS) co-infected with COVID-19 require essential and specialized medical care.
  • Further research is warranted to understand the mechanisms and optimize management strategies for MI in COVID-19 patients.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
24
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
12
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
12